Literature DB >> 20404570

miR-129 regulates cell proliferation by downregulating Cdk6 expression.

Junjie Wu1, Jun Qian, Chun Li, Letty Kwok, Feng Cheng, Peijun Liu, Catalina Perdomo, Darrell Kotton, Cyrus Vaziri, Christina Anderlind, Avrum Spira, Wellington V Cardoso, Jining Lü.   

Abstract

Reduced expression of miR-129 has been reported in multiple tumor cell lines and in primary tumors including medulloblastoma, undifferentiated gastric cancers, lung adenocarcinoma, endometrial cancer and colorectal carcinoma. There is also recent evidence of an anti-proliferative activity of miR-129 in tumor cell lines. Still, little is known about how miR-129 regulates cell proliferation. Here we found that lentiviral-mediated overexpression of miR-129 in mouse lung epithelial cells (E10 cells) results in significant G(1) phase arrest that eventually leads to cell death. miR-129 induce G(1) phase arrest in multiple human lung adenocarcinoma cell lines, suggesting miR-129 targeting of G(1)/S phase-specific regulators. Interestingly, we show that Cdk6, a kinase involved in G(1)-S transition, is a direct target of miR-129. We also found the downregulation of three other cell cycle-related novel targets of miR-129, including Erk1, Erk2 and protein kinase C epsilon (Prkce). We further show that among these targets, only Cdk6 is functionally relevant. Restoring expression of Cdk6, but not Prkce partially rescues the cell growth arrest and cell death phenotype that results from miR-129 overexpression. Together, our data indicate that miR-129 plays an important role in regulating cell proliferation by downregulation of Cdk6.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404570     DOI: 10.4161/cc.9.9.11535

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  80 in total

1.  Aberrant hypermethylation of miR-9 genes in gastric cancer.

Authors:  Kuo-Wang Tsai; Yu-Lun Liao; Chew-Wun Wu; Ling-Yueh Hu; Sung-Chou Li; Wen-Ching Chan; Meng-Ru Ho; Chun-Hung Lai; Hsiao-Wei Kao; Wen-Liang Fang; Kuo-Hung Huang; Wen-chang Lin
Journal:  Epigenetics       Date:  2011-10-01       Impact factor: 4.528

2.  MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair.

Authors:  E R Strickland; M A Hook; S Balaraman; J R Huie; J W Grau; R C Miranda
Journal:  Neuroscience       Date:  2011-04-07       Impact factor: 3.590

3.  miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics.

Authors:  Jingli Cao; Yidong Shen; Lei Zhu; Yanan Xu; Yizhuo Zhou; Zhili Wu; Yiping Li; Xiumin Yan; Xueliang Zhu
Journal:  Nat Cell Biol       Date:  2012-06-10       Impact factor: 28.824

4.  MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs.

Authors:  Mina Soufi-Zomorrod; Abbas Hajifathali; Fatemeh Kouhkan; Mahshid Mehdizadeh; Seyed Mohammad Ali Hosseini Rad; Masoud Soleimani
Journal:  Tumour Biol       Date:  2016-01-20

Review 5.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 6.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

Review 7.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

8.  miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.

Authors:  Xuanyu Chen; Anming Ruan; Xuegang Wang; Weiwei Han; Rong Wang; Ning Lou; Hailong Ruan; Bin Qiu; Hongmei Yang; Xiaoping Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-07       Impact factor: 4.553

Review 9.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

10.  Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.

Authors:  Hye-Min Jeon; Sung-Hak Kim; Xun Jin; Jong Bae Park; Se Hoon Kim; Kaushal Joshi; Ichiro Nakano; Hyunggee Kim
Journal:  Cancer Res       Date:  2014-06-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.